Key Takeaways
- Nvidia (NVDA) is set to invest up to $100 billion in OpenAI to significantly expand AI data center infrastructure, deploying at least 10 gigawatts of Nvidia systems, including millions of GPUs.
- Donald Trump claims the stock market has reached record highs, attributing the surge to investor confidence in his potential re-election, though some reports indicate a slight easing from these highs.
- HHS Secretary RFK Jr. announced a report linking prenatal acetaminophen (Tylenol) use to ADHD and autism diagnoses, prompting an expected FDA label update and public awareness campaign, and causing a significant drop in Kenvue (KVUE) stock.
- Geopolitical concerns remain elevated with Estonia reaffirming its commitment to Ukraine and confidence in U.S. allied defense, while the U.S. proposes Arab and Muslim nations send troops to Gaza.
In a significant development for the technology sector, Nvidia (NVDA) announced plans to invest a staggering up to $100 billion in OpenAI. This strategic partnership aims to build and deploy advanced AI data centers, equipped with at least 10 gigawatts of Nvidia's powerful systems, comprising millions of Graphics Processing Units (GPUs). The first phase of these systems, utilizing Nvidia's Vera Rubin platform, is anticipated to be operational in the latter half of 2026, solidifying Nvidia's role in the future of artificial intelligence infrastructure.
Meanwhile, former President Donald Trump asserted that the stock market has hit record highs, crediting the robust performance to investor belief in his re-election prospects. This claim comes as the Dow Jones Industrial Average, S&P 500, and Nasdaq have seen recent surges, though some market analysts noted a slight pullback on the day of the headline, partly due to new visa fee proposals.
The healthcare industry is facing a new challenge following an announcement by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. He revealed a report suggesting a link between prenatal use of acetaminophen, commonly known as Tylenol, and an increased risk of ADHD and autism diagnoses. This announcement is expected to trigger updated FDA labels and a new public awareness campaign, leading to a more than 10% drop in Kenvue (KVUE) stock, the company that owns Tylenol. The scientific community, however, remains divided on the definitive causal link, with ongoing research presenting varied conclusions.
On the geopolitical front, tensions persist with Estonia's Defense Minister Hanno Pevkur expressing strong confidence in the U.S.'s commitment to its allies amidst regional security concerns. This sentiment was echoed by Estonia's Foreign Minister Margus Tsahkna, who firmly stated that the country will never recognize the occupation of Ukrainian territories. These statements come as Estonia has pledged over €100 million in military aid to Ukraine for 2026 and recently experienced a "brazen" airspace violation by three Russian fighter jets, prompting calls for NATO consultations. Separately, the U.S. is reportedly seeking to enlist Arab and Muslim nations to deploy troops to Gaza to facilitate an Israeli withdrawal and secure transitional funding for the region. This proposal is part of broader discussions regarding post-conflict stability and reconstruction in Gaza.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.